Central Bank & Trust CO Moderna, Inc. Transaction History

Central Bank & Trust CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 13, 2023	SELL	$118.5 - $160.53 $1,185 - $1,605	-10 Reduced 6.33%	148 $17,000
Q1 2023 Apr 13, 2023	BUY	$135.66 - $197.02 $1,356 - $1,970	10 Added 6.76%	158 $24,000
Q1 2022 Apr 18, 2022	BUY	$126.46 - $235.05 $5,437 - $10,107	43 Added 40.95%	148 $25,000
Q2 2021 Jul 16, 2021	SELL	$129.91 - $234.98 $38,973 - $70,494	-300 Reduced 74.07%	105 $25,000
Q1 2021 Apr 20, 2021	SELL	$109.18 - $185.98 $24,565 - $41,845	-225 Reduced 35.71%	405 $53,000
Q4 2020 Jan 12, 2021	BUY	$65.74 - $169.86 $15,448 - $39,917	235 Added 59.49%	630 $66,000
Q3 2020 Oct 08, 2020	SELL	$54.34 - $94.85 $1,467 - $2,560	-27 Reduced 6.4%	395 $28,000
Q2 2020 Jul 15, 2020	BUY	$29.67 - $80.0 $12,520 - $33,760	422 New	422 $27,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Central Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Bank & Trust CO with notifications on news.